Every Form 4 that Molina Healthcare, Inc. (MOH) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow MOH and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full MOH filings page.
ZORETIC RICHARD C reported acquisition or exercise transactions in this Form 4 filing.
Director Richard C. Zoretic received a grant of 237 shares of Molina Healthcare common stock, awarded under the company’s 2025 Equity Incentive Plan for his board service. The award reflects a $55,000 quarterly portion of a $220,000 annual equity package, valued at a closing price of $232.55 per share. All 9,389 shares reported after the transaction are held indirectly through the Richard Charles Zoretic Revocable Living Trust.
WOLF DALE B reported acquisition or exercise transactions in this Form 4 filing.
Molina Healthcare director Dale B. Wolf received an equity grant of 237 shares of common stock, awarded through a trust, as part of his board compensation. The grant was made under the 2025 Equity Incentive Plan, valued at $55,000 based on the $232.55 closing price on July 1, 2026, bringing indirect holdings to 15,633 shares.
Schapiro Richard M reported acquisition or exercise transactions in this Form 4 filing.
Molina Healthcare director Richard M. Schapiro received a stock grant as part of his board compensation. He was awarded 237 shares of common stock on July 1, 2026 under the company’s 2025 Equity Incentive Plan, valued at $55,000 based on the closing price of $232.55 per share.
The filing explains this is one quarter of an annual equity award of $220,000 to each director, granted in four equal quarterly installments. Following this award, Schapiro directly holds 12,311 shares of Molina Healthcare common stock, reflecting ongoing, routine equity-based compensation for his service as a director.
ROMNEY RONNA reported acquisition or exercise transactions in this Form 4 filing.
Molina Healthcare director Ronna Romney received a stock grant through her revocable trust as part of routine board compensation. The trust was awarded 237 shares of common stock under the 2025 Equity Incentive Plan, based on the July 1, 2026 closing price of $232.55 per share.
This quarterly grant represents an equity value of $55,000, one quarter of a $220,000 annual equity award for directors. Following this award, the Ronna Romney Revocable Trust holds a total of 17,869 Molina Healthcare shares, reflecting ongoing compensation rather than an open-market purchase or sale.
ORLANDO STEVEN J reported acquisition or exercise transactions in this Form 4 filing.
Molina Healthcare director Steven J. Orlando, through the Orlando Family Trust, received a grant of 237 shares of common stock on July 1, 2026 under the company’s 2025 Equity Incentive Plan. The grant represents a quarterly equity award valued at $55,000, based on the $232.55 closing share price, as part of a $220,000 annual director equity package. Following this award, the trust holds 17,967 shares, and an additional 1,500 shares are held indirectly through Orlando’s 401(k) plan.
Lockhart Stephen H reported acquisition or exercise transactions in this Form 4 filing.
Molina Healthcare director Stephen H. Lockhart received a stock award rather than making an open-market purchase. He was granted 237 shares of common stock on July 1, 2026 at a reference price of $232.55 per share under the company’s 2025 Equity Incentive Plan.
This grant represents one quarterly installment of an annual equity award valued at $220,000 for each director, with $55,000 granted on the first day of each quarter based on the closing share price that day. After this award, Lockhart directly holds 4,384 Molina Healthcare shares.
GROHOWSKI LEO P reported acquisition or exercise transactions in this Form 4 filing.
Molina Healthcare director Leo P. Grohowski received a grant of 237 shares of Common Stock on July 1, 2026 as compensation for his board service. The shares were issued under Molina Healthcare’s 2025 Equity Incentive Plan at a price of $232.55 per share, based on the closing market price that day.
This quarterly equity award represents one quarter of an annual director equity value of $220,000, with $55,000 granted each quarter. Following this grant, Grohowski directly holds 1,542 shares of Molina Healthcare common stock.
SOISTMAN FRANCIS S JR reported acquisition or exercise transactions in this Form 4 filing.
Molina Healthcare director Francis S. Soistman Jr. received a grant of 237 shares of common stock on July 1, 2026. The shares were awarded under the company’s 2025 Equity Incentive Plan as part of his director compensation, based on the stock’s closing price of $232.55.
The filing notes that each director’s annual equity award is valued at $220,000, with $55,000 granted on the first day of each quarter. Following this grant, Soistman directly holds 907 shares of Molina Healthcare common stock.
BRASIER BARBARA L reported acquisition or exercise transactions in this Form 4 filing.
Molina Healthcare, Inc. director Barbara L. Brasier received a grant of 237 shares of common stock as part of her director compensation. The shares were granted under the company’s 2025 Equity Incentive Plan, based on the July 1, 2026 closing price of $232.55 per share.
The award represents one quarterly installment of a $220,000 annual equity award for each director, with this quarter’s portion set at $55,000. Following this grant, Brasier directly holds 5,818 shares of Molina Healthcare common stock, reflecting routine, compensation-related equity ownership rather than an open-market purchase or sale.
Molina Healthcare Chief Operating Officer James Woys acquired 144 shares of common stock under the company’s 2019 Employee Stock Purchase Plan. The shares were purchased at $147.51 per share, equal to 85% of the lower closing price of $173.54 during the offering period. Following this ESPP acquisition, Woys directly holds 90,178 shares of Molina Healthcare common stock.
Molina Healthcare, Inc. Chief Legal Officer Jeff D. Barlow increased his direct stake through the company’s employee stock purchase plan. He acquired 138 shares of common stock on June 30, 2026 at a plan price of $147.51 per share, bringing his direct holdings to 67,313 shares.
The shares were bought under Molina’s 2019 Employee Stock Purchase Plan, which sets the purchase price at 85% of the lower closing price on January 1, 2026 or June 30, 2026, using a reference price of $173.54. Footnotes also show that a portion of his broader equity awards will vest in tranches from March 2027 through March 2029.
Molina Healthcare EVP Debra Bacon reported routine share transactions tied to compensation and an employee plan. She acquired 23 shares of common stock on June 30, 2026 under the company’s 2019 Employee Stock Purchase Plan, with a purchase price equal to 85% of the $173.54 closing price on January 1, 2026. On July 1, 2026, 183 shares were surrendered at $232.55 per share to cover withholding taxes on the vesting of 529 shares. After these transactions, she directly holds 21,636 Molina Healthcare shares, and remaining restricted shares are scheduled to vest in March 2027, March 2028, and March 2029.
Molina Healthcare Chief Accounting Officer Maurice Hebert sold 600 shares of common stock in an open-market transaction at $191.55 per share. After the sale, he directly holds 12,815 shares. Footnotes indicate additional restricted shares are scheduled to vest in 2027, 2028, and 2029, with remaining awards already vested.
Molina Healthcare, Inc. Chief Legal Officer Jeff D. Barlow reported an open-market sale of 17,811 shares of common stock on May 11, 2026. The shares were sold at a volume-weighted average price of $186.12 per share, with individual trade prices ranging from $186.01 to $186.86. After this transaction, Barlow directly holds 67,175 shares of Molina Healthcare common stock. A related equity award is scheduled to vest in tranches of 7,296 shares on March 1, 2027, 6,193 shares on March 1, 2028, and 4,574 shares on March 1, 2029, with the remaining award already vested.
SOISTMAN FRANCIS S JR reported acquisition or exercise transactions in this Form 4 filing.
Molina Healthcare, Inc. director Francis S. Soistman Jr. received a grant of 170 shares of common stock on May 6, 2026 under the company’s 2025 Incentive Plan, as a prorated quarterly director award. The grant was valued at the closing price of $197.44 per share on that date, and following this award he directly holds 670 shares of Molina Healthcare common stock.
GROHOWSKI LEO P reported acquisition or exercise transactions in this Form 4 filing.
Molina Healthcare director Leo P. Grohowski received a grant of 405 shares of common stock on April 1, 2026. The award was made under Molina Healthcare’s 2025 Equity Incentive Plan as part of his compensation for board service.
The filing states that directors receive an annual equity award valued at $220,000, with one quarter, or $55,000, granted on the first day of each quarter based on the closing share price. The closing price on April 1, 2026 was $135.82, resulting in the 405-share grant. Following this award, Grohowski directly holds 1,305 shares of Molina Healthcare common stock.
Lockhart Stephen H reported acquisition or exercise transactions in this Form 4 filing.
Molina Healthcare, Inc. director Stephen H. Lockhart received a grant of 405 shares of common stock on April 1, 2026 under the company’s 2025 Equity Incentive Plan. The grant was valued at $55,000 based on a closing share price of $135.82, bringing his direct holdings to 4,147 shares.
This award represents one quarter of an annual equity grant of $220,000 provided to each director, with similar grants scheduled on the first day of each quarter using that day’s closing stock price.
ORLANDO STEVEN J reported acquisition or exercise transactions in this Form 4 filing.
Molina Healthcare director Steven J. Orlando, through the Orlando Family Trust, received a grant of 405 shares of common stock on April 1, 2026. The shares were awarded under Molina’s 2025 Equity Incentive Plan as part of his director compensation, based on the closing price of $135.82 per share that day, equating to a quarterly equity value of $55,000 toward an annual equity award of $220,000. After this grant, the Orlando Family Trust holds 17,730 shares of Molina common stock, and an additional 1,500 shares are held indirectly in the reporting person’s 401(k) plan.
WOLF DALE B reported acquisition or exercise transactions in this Form 4 filing.
Molina Healthcare director Dale B. Wolf received a grant of 405 shares of common stock on April 1, 2026 under the company’s 2025 Equity Incentive Plan, in connection with his board service. The award represents one quarterly installment of a $220,000 annual equity award, with this quarter’s $55,000 portion calculated using the April 1 closing price of $135.82 per share. Following this grant, indirect holdings for Wolf’s revocable trust increased to 15,396 shares of Molina Healthcare common stock.
ZORETIC RICHARD C reported acquisition or exercise transactions in this Form 4 filing.
Molina Healthcare director Richard C. Zoretic received an equity grant of 405 shares of common stock on April 1, 2026, held by the Richard Charles Zoretic Revocable Living Trust. The grant was made under the company’s 2025 Equity Incentive Plan as part of his director compensation.
The shares were valued using the closing price of $135.82 on April 1, 2026, equating to a quarterly equity award of $55,000 and an annual equity award target of $220,000. Following this grant, the trust holds a total of 9,152 Molina Healthcare shares.
Schapiro Richard M reported acquisition or exercise transactions in this Form 4 filing.
MOLINA HEALTHCARE, INC. director Richard M. Schapiro received a grant of 405 shares of common stock on April 1, 2026 under the company’s 2025 Equity Incentive Plan. The award represents one quarterly installment of a $220,000 annual equity grant, with this quarter’s $55,000 portion based on the $135.82 closing share price. Following the grant, Schapiro directly holds 12,074 common shares.
Molina Healthcare director Barbara L. Brasier received a grant of 405 shares of common stock as compensation for board service. The award was made on April 1, 2026 under the company’s 2025 Equity Incentive Plan. The quarterly grant was valued at $55,000, based on the $135.82 closing price of Molina Healthcare stock that day. Brasier now directly holds 5,581 shares following this non‑market, compensation-related acquisition.
ROMNEY RONNA reported acquisition or exercise transactions in this Form 4 filing.
Molina Healthcare director Ronna Romney received an equity grant through a revocable trust. On April 1, 2026, the Ronna Romney Revocable Trust was awarded 405 shares of Molina Healthcare common stock at a reference price of $135.82 per share under the company’s 2025 Equity Incentive Plan. This quarterly grant represents one quarter of an annual director equity award valued at $220,000, structured as $55,000 in stock each quarter based on the closing market price that day. Following this award, the trust holds a total of 17,632 shares, reflecting routine, compensation-related ownership rather than an open-market purchase or sale.
Molina Healthcare director Ronna Romney, through the Ronna Romney Revocable Trust, reported an open-market sale of 506 shares of Common Stock on March 12, 2026. The shares were sold at a volume-weighted average price of $146.92 per share, with individual trade prices ranging from $146.80 to $147.10.
Following this transaction, the trust continues to hold 17,227 Molina Healthcare shares indirectly attributed to Romney. The sale represents a relatively small portion of the trust’s overall reported holdings and appears as a routine portfolio adjustment rather than a large position change.
Molina Healthcare President & CEO Joseph M. Zubretsky reported equity compensation transactions in company common stock. On March 1, 2026, 8,597 shares were disposed of at $154.05 per share to cover withholding taxes tied to the vesting of 20,623 shares of previously granted stock.
On the same date, he received a grant of 66,417 restricted shares at a reference price of $145.75, determined using the volume-weighted average price over the ten trading days before March 1, 2026, under the 2025 Equity Incentive Plan. These 66,417 shares are scheduled to vest in three equal installments on March 1, 2027, March 1, 2028, and March 1, 2029, with additional tranches of 13,075 shares vesting on March 1, 2027 and 7,497 shares on March 1, 2028.
After these transactions, he directly owned 99,015 shares and indirectly held 257,715 shares through the Joseph M. Zubretsky Revocable Trust, where he serves as sole trustee.
Molina Healthcare’s Chief Financial Officer Mark Lowell Keim reported equity compensation activity involving the company’s common stock. On March 1, 2026, he received a grant of 26,073 restricted shares under the 2025 Equity Incentive Plan at a reference price of $145.75 per share, based on a 10‑day VWAP. On the same date, 2,308 shares valued at $154.05 per share were withheld to cover taxes tied to the vesting of 6,563 shares, rather than sold on the open market. After these transactions, he directly held 83,251 shares of Molina Healthcare common stock. The new grant vests in one‑third increments on March 1, 2027, March 1, 2028, and March 1, 2029, with additional scheduled vesting of 4,613 shares on March 1, 2027 and 2,892 shares on March 1, 2028.
Molina Healthcare Chief Operating Officer James Woys reported two equity-related transactions in company common stock. On March 1, 2026, 1,313 shares were disposed of to cover withholding taxes triggered by the vesting of 5,337 shares, using a price of $154.05 per share, leaving 73,018 shares directly held after this step.
On the same date, he received a grant of 17,016 restricted shares under the 2025 Equity Incentive Plan at $145.75 per share, based on a volume-weighted average price for the 10 trading days before March 1, 2026. These 17,016 shares vest in three equal installments on March 1, 2027, 2028, and 2029. Additional unvested tranches include 3,632 shares vesting on March 1, 2027 and 2,082 shares on March 1, 2028. After the grant, he directly held 90,034 shares.
Molina Healthcare Chief Accounting Officer Maurice Hebert reported a mix of stock awards and tax-related share withholdings. On March 1, 2026, he received 650 shares of common stock issued in settlement of performance stock units granted on March 1, 2023, based on three-year average adjusted earnings per share at an 89% vesting level. The company also withheld 229 shares and 272 shares, at a price of $154.05, to cover tax liabilities tied to these vestings. In a separate transaction on the same date, Hebert received a grant of 2,058 restricted shares under the 2025 Equity Incentive Plan at a reference price of $145.75, which will vest in stages through March 1, 2029. After these transactions, he directly owned 11,357 shares of Molina Healthcare common stock.
Molina Healthcare, Inc. Chief Legal Officer Jeff D. Barlow reported equity compensation changes on March 1, 2026. He received a grant of 13,722 shares of common stock under the company’s 2025 Equity Incentive Plan at a reference price of $145.75 per share, based on a 10‑day volume-weighted average price.
On the same date, 1,638 shares were withheld at $154.05 per share to cover tax obligations tied to the vesting of 4,183 shares, a non‑open‑market, tax-withholding disposition. After these transactions, his directly held common stock increased to 84,986 shares, with the new grant vesting in stages through March 1, 2029.
Molina Healthcare executive Debra Bacon reported equity compensation activity and related tax withholding. On March 1, 2026, 716 shares of common stock at $154.05 per share were withheld and disposed of to cover taxes tied to the vesting of 2,021 shares. The price reflects the closing price on February 27, 2026.
On the same date, Bacon received a grant of 9,606 restricted shares of Molina Healthcare common stock under the company’s 2025 Equity Incentive Plan at a reference price of $145.75, based on a 10-day volume-weighted average price. These 9,606 shares vest in three equal installments on March 1 of 2027, 2028, and 2029, with additional previously granted shares scheduled to vest on July 1, 2026 and March 1, 2027 and 2028. After these transactions, she directly held 21,796 common shares.
Molina Healthcare, Inc. director Richard C. Zoretic reported an indirect open-market purchase of company stock through a trust associated with him. On 02/11/2026, the Richard Charles Zoretic Revocable Living Trust bought 800 shares of Molina Healthcare common stock at $125.16 per share.
Following this transaction, the trust beneficially owns 8,747 shares of Molina Healthcare common stock, all reported as indirect ownership by Zoretic.
Molina Healthcare director reports quarterly stock grant under equity plan
A director of Molina Healthcare, Inc. received a grant of 317 shares of common stock on January 1, 2026 under the company’s 2025 Equity Incentive Plan, in connection with service as a director. The grant value was based on an annual equity award of $220,000 per director, with one quarter, or $55,000, granted on the first day of each quarter.
Because January 1, 2026 was a non-trading day, the share amount was calculated using the $173.54 closing price of Molina Healthcare common stock on December 31, 2025. Following this transaction, the reporting person beneficially owned 17,325 shares held by a family trust and 1,500 shares held in the reporting person’s 401(k) plan, all reported as indirect ownership.
Molina Healthcare, Inc. reported an insider equity award to one of its directors. On January 1, 2026, the director received 317 shares of common stock as a grant under the company’s 2025 Equity Incentive Plan for board service. The award represents one quarter of an annual equity value of $220,000, with this quarterly portion set at $55,000.
The number of shares was calculated using the common stock closing price of $173.54 on December 31, 2025. Following this grant, the director directly beneficially owns 3,742 shares of Molina Healthcare common stock.
Molina Healthcare director Ronna Romney, through the Ronna Romney Revocable Trust, received a grant of 317 shares of common stock on January 1, 2026 under the company’s 2025 Equity Incentive Plan for her services as a director. The quarterly grant amount was based on an equity value of $55,000, using the $173.54 closing price of Molina Healthcare’s common stock on December 31, 2025 because January 1 was a non-trading day.
Following this grant, the trust beneficially owns 17,733 shares of Molina Healthcare common stock. The filing indicates this Form 4 is for a single reporting person and reflects routine, formula-based director compensation rather than an open-market purchase or sale.
Molina Healthcare, Inc. reported that one of its directors received a grant of common stock as part of the company’s equity compensation program. On January 1, 2026, the director was granted 317 shares of Molina Healthcare common stock under the company’s 2025 Equity Incentive Plan for services as a director. The quarterly equity award was set at a dollar value of $55,000, determined by dividing that amount by the stock’s closing price of $173.54 on December 31, 2025, resulting in the 317-share grant. Following this transaction, the director beneficially owned 11,669 shares of Molina Healthcare common stock, held directly.
Molina Healthcare, Inc. reported that Director Richard C. Zoretic received a quarterly stock grant under the company’s 2025 Equity Incentive Plan for his board service. The award is part of an annual equity grant valued at $220,000 for each director, paid in four quarterly installments of $55,000.
For the quarter beginning January 1, 2026, the grant was set at 317 shares of common stock, calculated using the December 31, 2025 closing price of $173.54 because January 1 was a non-trading day. After this transaction, 7,947 shares of Molina Healthcare common stock are reported as beneficially owned indirectly through the Richard Charles Zoretic Revocable Living Trust.
Molina Healthcare director receives routine equity compensation in stock. A company director was granted 317 shares of Molina Healthcare common stock on January 1, 2026 under the 2025 Equity Incentive Plan, for services as a director. The grant represents one quarterly installment of an annual equity award with an aggregate value of $220,000, with this quarter’s portion set at $55,000. Because January 1, 2026 was a non-trading day, the shares were calculated using the December 31, 2025 closing price of $173.54 per share. Following this grant, the director beneficially owns 900 shares directly.
Molina Healthcare director reports routine stock grant
A director of Molina Healthcare, Inc. reported receiving 317 shares of common stock on January 1, 2026 under the company’s 2025 Equity Incentive Plan for board service. The quarterly grant represents one quarter of an annual equity award valued at $220,000, with this quarter’s $55,000 portion calculated using the $173.54 closing price of Molina Healthcare common stock on December 31, 2025, because January 1 was a non-trading day.
After this award, the reporting person beneficially owns 14,991 shares of Molina Healthcare common stock, held indirectly through the Dale B. Wolf Revocable Trust, for which he serves as sole trustee. The filing describes this as compensation for services as a director rather than an open-market purchase or sale.
Molina Healthcare, Inc. reported a routine equity grant to one of its directors. On January 1, 2026, the director received 317 shares of Molina common stock under the company’s 2025 Equity Incentive Plan as compensation for board service. The grant represents one quarterly portion of an annual equity award valued at $220,000, with this quarter’s installment set at $55,000.
The number of shares was calculated using the closing price of Molina’s common stock of $173.54 on December 31, 2025, because the grant date was a non‑trading day. Following this grant, the director beneficially owns 5,176 shares of Molina Healthcare common stock, held directly.
Molina Healthcare executive Debra Bacon, EVP of Medicaid, reported acquiring company stock through an employee plan. On December 31, 2025, she purchased 22 shares of common stock under the Molina Healthcare, Inc. 2019 Employee Stock Purchase Plan. The purchase price was $147.51 per share, equal to 85% of $173.54, which was the closing price on the last trading day of the ESPP offering period. After this transaction, she beneficially owns 12,906 shares directly. The filing also notes a vesting schedule for previously granted shares, with tranches vesting on March 1, 2026, July 1, 2026, March 1, 2027, and March 1, 2028.
Molina Healthcare, Inc. (MOH) reported an insider stock transaction by one of its directors. On 11/24/2025, the director sold 357 shares of Molina common stock in an open-market transaction coded as a sale.
The shares were sold at a volume-weighted average price of $143.02, with individual trade prices ranging from $143.00 to $143.18. Following this transaction, the director beneficially owns 11,352 shares of Molina Healthcare common stock, held in direct ownership form.
The filing shows that Ronna Romney, a director of Molina Healthcare, Inc. (MOH), received an equity grant under the company’s 2025 Equity Incentive Plan on 10/01/2025. The award represents a quarterly portion of the director annual equity retainer of $220,000, with one quarter equal to $55,000. Based on the closing stock price of $192.79 on the grant date, the grant comprised 285 shares.
After the grant, the filing reports 17,416 shares beneficially owned by Ms. Romney, held indirectly through the Ronna Romney Revocable Trust. The Form 4 was signed by a power of attorney on 10/02/2025. The disclosure is a routine director equity compensation report and records the grant price and the indirect ownership vehicle.